Phytohealth Corp (TW:4108) — Market Cap & Net Worth
Market Cap & Net Worth: Phytohealth Corp (4108)
Phytohealth Corp (TW:4108) has a market capitalization of $70.71 Million (NT$2.24 Billion) as of August 1, 2026. Listed on the TW stock exchange, this Taiwan-based company holds position #20484 globally and #1205 in its home market, demonstrating a -3.83% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Phytohealth Corp's stock price NT$11.30 by its total outstanding shares 198619000 (198.62 Million). See 4108 capital expenditure intensity to understand how much of operating cash flow is reinvested back into capital assets.
Phytohealth Corp Market Cap History: 2015 to 2026
Phytohealth Corp's market capitalization history from 2015 to 2026. Data shows change from $169.02 Million to $70.71 Million (-8.39% CAGR).
Phytohealth Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Phytohealth Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.63x
Phytohealth Corp's market cap is 0.63 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $185.40 Million | $25.02 Million | -$194.52 Million | 7.41x | N/A |
| 2017 | $141.10 Million | $54.00 Million | -$206.35 Million | 2.61x | N/A |
| 2018 | $109.85 Million | $107.48 Million | -$182.48 Million | 1.02x | N/A |
| 2019 | $109.24 Million | $95.48 Million | -$170.93 Million | 1.14x | N/A |
| 2020 | $153.54 Million | $91.81 Million | -$118.66 Million | 1.67x | N/A |
| 2021 | $145.80 Million | $168.94 Million | -$78.02 Million | 0.86x | N/A |
| 2022 | $119.52 Million | $135.47 Million | -$115.03 Million | 0.88x | N/A |
| 2023 | $135.79 Million | $162.49 Million | -$47.12 Million | 0.84x | N/A |
| 2024 | $105.13 Million | $153.56 Million | -$73.50 Million | 0.68x | N/A |
| 2025 | $84.48 Million | $134.58 Million | -$58.20 Million | 0.63x | N/A |
Competitor Companies of 4108 by Market Capitalization
Companies near Phytohealth Corp in the global market cap rankings as of August 1, 2026.
Key companies related to Phytohealth Corp by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #503 globally with a market cap of $52.60 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #528 globally with a market cap of $50.48 Billion USD ( CN¥344.98 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #550 globally with a market cap of $48.78 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #503 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #528 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.48 Billion | CN¥54.08 |
| #550 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $43.60 |
| #619 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €15.50 |
Phytohealth Corp Historical Marketcap From 2015 to 2026
Between 2015 and today, Phytohealth Corp's market cap moved from $169.02 Million to $ 70.71 Million, with a yearly change of -8.39%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$70.71 Million | -16.30% |
| 2025 | NT$84.48 Million | -19.64% |
| 2024 | NT$105.13 Million | -22.58% |
| 2023 | NT$135.79 Million | +13.61% |
| 2022 | NT$119.52 Million | -18.03% |
| 2021 | NT$145.80 Million | -5.04% |
| 2020 | NT$153.54 Million | +40.55% |
| 2019 | NT$109.24 Million | -0.55% |
| 2018 | NT$109.85 Million | -22.15% |
| 2017 | NT$141.10 Million | -23.89% |
| 2016 | NT$185.40 Million | +9.69% |
| 2015 | NT$169.02 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 1st, 2026 the market cap of Phytohealth Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $70.71 Million USD |
| MoneyControl | $70.71 Million USD |
| MarketWatch | $70.71 Million USD |
| marketcap.company | $70.71 Million USD |
| Reuters | $70.71 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Phytohealth Corp
PhytoHealth Corporation researches, develops, manufactures, and sells medicines, cosmetics, Class B medicines, complementary foods, and other related products in Taiwan. It operates in three segments: Medicines and Health Food, Medical Diagnosis, and Precision Medical Equipment and Instruments. The Medicines and Health Food segment manufactures and sells Chinese medicine materials and new drugs. … Read more